By Editor • August 27, 2026 • 1 min read
Moderna's personalized cancer vaccine may become the first approved treatment with mRNA instructions generated by AI, following a successful trial with Merck.
Read moreBy Editor • August 24, 2026 • 1 min read
Moderna and Merck's cancer vaccine shows early promise in reducing melanoma recurrence, but skepticism remains among experts and investors.
Read moreBy Editor • August 19, 2026 • 1 min read
A new mRNA drug has shown promising results in preventing melanoma recurrence, marking a milestone in cancer treatment.
Read more
